Danish Diabetes Academy
11
1
2
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
27%
3 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Metabolic Effects of β-hydroxybutyrate on Working Skeletal Muscle
Role: collaborator
Polyamine Treatment in Elderly Patients With Coronary Artery Disease
Role: collaborator
mTOR as Mediator of Insulin Sensitivity Study
Role: collaborator
The Importance of Sleep for Diabetes Associated Tasks and Outcomes
Role: collaborator
Postprandial VLDL-triglyceride Metabolism in Type 2 Diabetes Patients With and Without NAFLD
Role: collaborator
Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes
Role: collaborator
Hepatic and Cardiac Metabolic Flexibility in Subjects With T2DM With and Without NAFLD
Role: collaborator
A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes
Role: collaborator
The Influence of High and Low Salt on Exosomes in the Urine
Role: collaborator
The Late Effects of Ethanol Intake on the Glucose Response to Subcutaneous Glucagon in Type 1 Diabetes
Role: collaborator
Glucagon Efficiency After High and Low Carbohydrate Diet
Role: collaborator
All 11 trials loaded